TMEM241: A Potential Drug Target and Chromatin Regulation Protein

Target Name: TMEM241

NCBI ID: G85019

TMEM241

TMEM241: A Potential Drug Target and Chromatin Regulation Protein

TMEM241 (SLC35D4) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of transmembrane protein (SMP) and is characterized by its unique transmembrane structure and various post-translational modifications (PTMs) that regulate its stability and localization to specific cell types.

TMEM241 has been identified as a potential drug target due to its involvement in various physiological processes, including cell signaling, neurotransmission, and chromatin regulation. Its expression has also been implicated in various diseases, including neurodegenerative disorders, diabetes, and cancer.

One of the key features of TMEM241 is its SLC (sodium-dependent carrier) mechanism of transport, which allows it to be easily targeted to the brain and other areas of the body with high affinity. This is especially important for its role in modulating neurotransmitter release and intracellular signaling, as well as its involvement in the regulation of ion channels and the balance of electrical potential in the nervous system.

In addition to its role in neurotransmission, TMEM241 has also been shown to play a key role in the regulation of chromatin structure and function. It has been shown to interact with various nuclear proteins and to regulate the distribution of chromatin modifications, including histone modifications and non-histone modifications.

The potential drug targets for TMEM241 are vast, and research into its function and interaction with the nervous system is ongoing. One of the primary targets for TMEM241 is its role in neurotransmission, with researchers interested in understanding how it modulates the release of neurotransmitters and how this modulation is affected by various environmental and genetic factors.

Another potential target for TMEM241 is its role in chromatin regulation. Researchers are interested in understanding how it interacts with chromatin-remodeling enzymes and how this interaction contributes to the regulation of chromatin structure and function.

In addition to its potential drug targets, TMEM241 also has potential as a biomarker for various diseases, including neurodegenerative disorders, diabetes, and cancer. Its expression has been shown to be altered in these conditions, and its levels have been used as a diagnostic or predictive marker in various studies.

Overall, TMEM241 is a protein that has significant implications for our understanding of various physiological processes and has the potential to be a drug or biomarker target. Further research is needed to fully understand its role in the nervous system and its potential as a therapeutic agent.

Protein Name: Transmembrane Protein 241

The "TMEM241 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM241 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets